Dr. Raza Hassan Orakzai, MD

Dr. Orakzai practices at Franciscan Digestive Care Associates Lakewood - HOPD in Lakewood, Washington.

Dr. Orakzai's NPI, 1083871180, was assigned on May 18, 2008. Dr. Orakzai holds Washington license MD60359987.

Dr. Orakzai's primary practice is Franciscan Digestive Care Associates Lakewood - HOPD, at 11311 Bridgeport Way SW, Lakewood, WA 98499.

Dr. Orakzai's primary practice is Franciscan Digestive Care Associates Lakewood - HOPD in Lakewood, Washington. Dr. Orakzai is also affiliated with St. Clare Hospital. The medical group on file is Franciscan Orthopedics - Silverdale. Dmand AI also links Dr. Orakzai to 3 more hospitals and 1 group practice or clinic, each named with a free account. Dr. Orakzai's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Orakzai practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Orakzai's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Orakzai's licenses on file in 3 states: Washington, Arizona and California.

CMS data shows 2,677 Medicare services from Dr. Orakzai across 20 procedure codes in 2024, for 1,208 Medicare patients. Medicare paid $154,805 for them.

CMS counts 1,208 Medicare patients who saw Dr. Orakzai in 2024. The largest group is 75 to 84, with 482 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Orakzai's median patient age at 69, with 49% women.

In 2024, Dr. Orakzai wrote 3,869 Medicare Part D claims for 619 patients. 83% of them were for generic drugs. CMS names the drug for 3,706 of them, across 39 drugs with 11 or more claims each, at $727,789 in total drug cost. In 2023, CMS named 3,196 claims across 38 drugs.

Dr. Orakzai accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Orakzai as offering telehealth.

Dmand AI links 1 paper to Dr. Orakzai. Dr. Orakzai's most frequent co-authors are Daniel S. Berman, MD, Matthew J. Budoff, MD and Sean W. Hayes, MD.

CMS Open Payments shows 26 general payments to Dr. Orakzai from 5 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 74% of the total. Lantheus Medical Imaging, Inc. paid the most, $11,611.